Chemistry: molecular biology and microbiology – Vector – per se
Patent
1996-09-18
1999-11-09
Ketter, James
Chemistry: molecular biology and microbiology
Vector, per se
435243, 435349, 435370, C12N 1586
Patent
active
059812745
ABSTRACT:
The present invention relates to recombinant hepatitis viral vectors useful for the expression of functional heterologous gene products in liver cells. It is contemplated that these vectors will find use in anti-viral, anti-tumor and/or gene therapy, particularly for the correction of inherited single-gene defects. These novel recombinant vectors may be used to deliver genes to cells in vivo by a variety of means including infection and direct injection of vector DNA.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
Huber et al. (1991) "Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy," Proc. Natl. Acad. Sci. USA 88:8039-8043.
Chowdhury et al. "Long-Term Improvement of Hypercholesterolemia After ex Vivo Gene Therapy in LDLR-Deficient Rabbits," Science 254:1802-1805.
Ledley et al. (1987) "Retroviral gene transfer into primary hepatocytes: Implications for genetic therapy of liver-specific functions," Proc. Natl. Acad. Sci. USA 84:5335-5339.
Wilson et al. (1988) "Retrovirus-mediated transduction of adult hepatocytes," Proc. Natl. Acad. Sci. USA 85:3014-3018.
Wolff et al. (1987) "Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes," Proc. Natl. Acad. Sci. USA 84:3344-3348.
Jaffe et al. (1992) "Adenovirus-mediated in vivo gene transfer and expression in normal rat liver," Nature Gent. 1:372-378.
Kaneda et al. (1989) "Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver," Science 243:375-378.
Wu et al. (1989) "Targeting Genes: Delivery and Persistent Expression of a Foreign Gene Driven by Mammalian Regulatory Elements in Vivo," J. Biol. Chem. 264(29):16985-16987.
Wilson (1992) "Hepatocyte-directed Gene Transfer in Vivo Leads to Transient Improvement of Hypercholesterolemia in Low Density Lipoprotein Receptor-deficient Rabbits," J. Biol. Chem. 267:963-967.
Maniatis et al. (1987) "Regulation of Inducible and Tissue-Specific Gene Expression," Science 236:1237-1245.
Voss et al. (1986) "The role of enhancers in the regulation of cell-type-specific transcriptional control," Trends Biochem. Sci. 11:287-289.
Dijkema et al. (1985) "Cloning and expression of the chromosomal immune interferon gene of the rat," EMBO J. 4:761-767.
Uetsuki et al. (1989) "Isolation and Characterization of the Human Chromosomal Gene for Polypeptide Chain Elongation Factor-1a," J. Biol. Chem. 264:5791-5798.
Kim et al. (1990) "Use of the human elongation factor 1.alpha. promoter as a versatile and efficient expression system," Gene 91:217-223.
Mizushima and Nagata (1990) "pEF-BOS, a powerful mammalian expression vector," Nuc. Acids. Res. 18:5322.
Gorman et al. (1982) "The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection," Proc. Natl. Acad. Sci. USA 79:6777-6781.
Boshart et al. (1985) "A Very Strong Enhancer Is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus," Cell 41:521-530.
Sambrook, J. et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, NY, pp. 7.39-7.52.
Blum et al. (1988) "Latent hepatitis B virus infection with full-length viral genome in a patient serologically immune to hepatitis B virus infection," Liver 8:307-316.
Ganem and Varmus (1987) "The Molecular Biology of the Hepatitis B Viruses," Ann. Rev. Biochem. 56:651-693.
Nassal and Schaller (1993) "Hepatitis B virus replication," Trends Microbiol. 1:221-228.
Rossner (1992) "Review: Hepatitis B Virus X-Gene Product: A Promiscuous Transcriptional Activator," J. Med. Virol. 36:101-117.
Bartenschlager and Schaller (1988) "The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription," EMBO J. 7:4185-4192.
Radziwill et al. (1990) "Mutational Analysis of the Hepatitis B Virus P Gene Product: Domain Structure and RNase H Activity," J. Virol. 64:613-620.
Schaller and Fischer (1991) "Transcriptional Control of Hepadnavirus Gene Expression," Curr. Top. Microbiol. Immunol. 168:21-39.
Chang et al. (1990) "Effects of Insertional and Point Mutations on the Functions of the Duck Hepatitis B Virus Polymerase," J. Virol. 64:5553-5558.
Eglitis et al. (1985) "Gene Expression in Mice After High Efficiency Retroviral-Mediated Gene Transfer," Science 230:1395-1398.
Miller et al. (1993) "Use of Retroviral Vectors for Gene Transfer and Expression," Methods Enzymol. 217:581-599.
Naldini et al. (1996) "In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector," Science 272:263-267.
Beames and Lanford (1995) "Insertions within the Hepatitis B Virus Capsid Protein Influence Capsid Formation and RNA Encapsidation," J. Virol. 69:6833-6838.
Faruqi et al. (1991) "Short Communications: Replication-Defective Missense Mutations within the Terminal Protein and Spacer/Intron Regions of the Polymerase Gene of Human Hepatitis B Virus," Virol. 183:764-768.
Machein et al. (1992) "Deletion and insertion mutants of HBsAg particles," Arch. Virol. [Suppl] 4:133-136.
Melegari et al. (1994) "Properties of Hepatitis B Virus Pre-Sl Deletion Mutants," Virol. 199:292-300.
Nakatake et al. (1993) "Effect of X Protein on Transactivation of Hepatitis B Virus Promoters and on Viral Replication," Virol. 95:305-314.
Bartenschlager et al. (1990) "The P Gene Product of Hepatitis B Virus Is Required as a Structural Component for Genomic RNA Encapsidation," J. Virol. 64:5324-5332.
Hirsch et al. (1990) "Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription," Nature 344:552-555.
Li et al. (1989) "Duck Hepatitis B Virus Can Tolerate Insertion, Deletion, and Partial Frameshift Mutation in the Distal Pre-S Region," J. Virol. 63:4965-4968.
Takebe et al. (1988) "SR.alpha. Promoter: an Efficient and Versatile Mammalian cDNA Expression System Composed of the Simian Virus 40 Early Promoter and the R-U5 Segment of Human T-Cell Leukemia Virus Type 1 Long Terminal Repeat," Mol. Cell. Biol. 8:466-472.
Graham et al. (1977) "Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5," J. Gen. Virol. 36:59-72.
Harrison et al. (1977) "Host-Range Mutants of Adenovirus Type 5 Defective for Growth in HeLa Cells," Virology 77:319-329.
Graham et al. (1978) "Defective Transforming Capacity of Adenovirus Type 5 Host-Range Mutants," Virology 86:10-21.
Robinson (1990) "Hepadnaviridae and Their Replication," in Hepadnaviridae and their replication, Fields et al. eds., Fields Virology, Raven Press, Ltd. N.Y., pp. 2137-2169.
Robinson et al. (1995) "Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat," Gene Therapy 2:269-278.
Chang et al. (1993) "Human Immunodeficiency Viruses Containing Heterologous Enhancer/Promoters Are Replication Competent and Exhibit Different Lymphocyte Tropisms," J. Virol. 76:743-752.
Peterlin et al. (1986) "Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus," Proc. Natl. Acad. Sci. USA 83:9734-9738 (1986).
Condreay et al. (1990) "Efficient Duck Hepatitis B Virus Production by an Avian Liver Tumor Cell Line," J. Virol. 64:3249-3258.
Shaul (1991), Regulation of hepadnavirus transcription, A McLachlan (ed.), in Molecular biology of hepatitis B viruses, CRC Press, Boca Raton, FL; This reference is not currently available; should the Examiner desire a copy, please let Applicants know so that one may be provided.
Patel et al. (1989) "Interactions between Nuclear Factors and the Hepatitis B Virus Enhancer," J. Virol. 63:5293-5301.
Jameel and Siddiqui (1986) "The Human Hepatitis B Virus Enhancer Requires trans-Acting Cellular Factor(s) for Activity," Mol. Cell. Biol. 6:710-715.
Siddiqui et al. (1989) "trans-Activation of Viral Enhancers Including Long Terminal Repeat of the Human Immunodeficiency Virus by the Hepatitis B Virus X Protein," Virol. 169:479-484.
Twu et al. (1990) "Transcri
Chaisomchit Sumonta
Chang Lung-Ji
Tyrrell D. Lorne J.
Cooper Iver P.
Ketter James
Yucel Irem
LandOfFree
Recombinant hepatitis virus vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant hepatitis virus vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant hepatitis virus vectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1454620